Thursday, February 16, 2017
Sunday, February 5, 2017
Free Online Issue Current Medicinal Chemistry Vol. 24 Issue 1
Free Online Issue Current Medicinal Chemistry Vol. 24 Issue 1
Subscribe to:
Posts (Atom)
Open Access Articles
Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review
A “Double-Edged” Scaffold: Antitumor Power within the Antibacterial Quinolone
Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review
A “Double-Edged” Scaffold: Antitumor Power within the Antibacterial Quinolone
Bentham Science: An Introduction
Bentham Science: An Introduction
We have been serving the needs of STM field since 1992 and publish 117 titles, fulfilling the information needs for the Pharmaceutical and Biomedical research community. We are publishers of many high impact factor Journals and eBook
Contact
Subscription Department:
Bentham Science Publishers.
Executive Suite Y - 2
P.O.Box 7917, Saif Zone
Sharjah,
U.A.E.
Tel: +971-6-5571132
Fax: +971-6-5571134
Email: subscriptions@benthamscience.org
About
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.